46.46.Z - Wholesale trade of pharmaceutical and medical products
20.42.Z - Manufacture of cosmetics and toilet preparations
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
70.22.Z - Head office activities and management consultancy
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 9,5 | 10,4 | 11,9 | 13,8 |
EBITDA | 10,3 | 10,2 | 11,8 | 16 |
Short time liabilities | 6,8 | 14,4 | 6,4 | -55,3 |
Equity capital | 62,3 | 32,9 | 34,1 | 3,5 |
Operating profit (EBIT) | 9,5 | 9,5 | 11,3 | 18,7 |
Assets | 69,6 | 47,6 | 41,6 | -12,6 |
Net profit (loss) | 7,8 | 8,4 | 9,6 | 13,7 |
Cash | 49,3 | 24,3 | 19 | -21,9 |
Liabilities and provisions for liabilities | 7,3 | 14,7 | 7,6 | -48,5 |
Net income from sale | 38,7 | 41,7 | 47,2 | 13,2 |
Working assets | 62,8 | 41,2 | 34,1 | -17,1 |
Depreciation | 0,8 | 0,7 | 0,5 | -21,5 |
% | % | % | p.p. | |
Profitability of capital | 12,5 | 25,6 | 28,1 | 2,5 |
Equity capital to total assets | 89,6 | 69,1 | 81,8 | 12,7 |
Gross profit margin | 24,7 | 25 | 25,1 | 0,1 |
EBITDA Margin | 26,5 | 24,4 | 25 | 0,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 65 | 126 | 50 | -76 |
Current financial liquidity indicator | 8.928979873657227 | 2.82673716545105 | 5.144134521484375 | 2,3 |
Net dept to EBITDA | -4.736798286437988 | -2.336111068725586 | -1.5086662769317627 | 0,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane